Back to Search
ALESSANDRO TESTORI, MD PHD
MD PHD
Internal Medicine Physician
NPI: 1326057050IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
48867(CO)
CMS Specialties
PrimaryINTERNAL MEDICINE
Education
OTHER
Class of 2003
Research & Publications (20)
Clinical considerations on sentinel node biopsy in melanoma from an Italian multicentric study on 1,313 patients (SOLISM-IMI).
PMID 19132446·Ann Surg Oncol·2009
3-trial
Surgery and radiotherapy in the treatment of cutaneous melanoma.
PMID 19617294·Ann Oncol·2009
6-review
Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trial.
PMID 18620949·Lancet·2008
3-trial
Phase III comparison of vitespen, an autologous tumor-derived heat shock protein gp96 peptide complex vaccine, with physician's choice of treatment for stage IV melanoma: the C-100-21 Study Group.
PMID 18281670·J Clin Oncol·2008
3-trial
The role of ultrasound of sentinel nodes in the pre- and post-operative evaluation of stage I melanoma patients.
PMID 15917701·Melanoma Res·2005
4-observational
Diagnosis of melanoma in the elderly and surgical implications.
PMID 15615659·Surg Oncol·2004
6-review
Autologous peripheral blood CD133+ cell implantation for limb salvage in patients with critical limb ischemia.
PMID 19448678·Bone Marrow Transplant·2010
8-other
Serum concentrations of pegylated interferon alpha-2b in patients with resected stage III melanoma receiving adjuvant pegylated interferon alpha-2b in a randomized phase III trial (EORTC 18991).
PMID 19621225·Cancer Chemother Pharmacol·2010
3-trial
Desmoid tumors of the anterior abdominal wall: results from a monocentric surgical experience and review of the literature.
PMID 19296178·Ann Surg Oncol·2009
8-other
Adjuvant therapy with pegylated interferon alfa-2b versus observation in resected stage III melanoma: a phase III randomized controlled trial of health-related quality of life and symptoms by the European Organisation for Research and Treatment of Cancer Melanoma Group.
PMID 19433686·J Clin Oncol·2009
3-trial
Clinical genetic testing for familial melanoma in Italy: a cooperative study.
PMID 19500876·J Am Acad Dermatol·2009
4-observational
Autologous non-myeloablative haemopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: a phase I/II study.
PMID 19186105·Lancet Neurol·2009
3-trial
A phase I-II study of the histone deacetylase inhibitor valproic acid plus chemoimmunotherapy in patients with advanced melanoma.
PMID 19127265·Br J Cancer·2009
3-trial
Oncophage: step to the future for vaccine therapy in melanoma.
PMID 18990084·Expert Opin Biol Ther·2008
6-review
Modification of lymphoscintigraphic sentinel node identification before and after excisional biopsy of primary cutaneous melanoma.
PMID 19011509·Melanoma Res·2008
8-other
Genomic rearrangements of the CDKN2A locus are infrequent in Italian malignant melanoma families without evidence of CDKN2A/CDK4 point mutations.
PMID 19011513·Melanoma Res·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 1551 PROFESSIONAL LN UNIT 170
LONGMONT, CO 80501 - Phone
- (303) 776-0868
Quick Facts
- NPI
- 1326057050
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 2
- Years in Practice
- 23
- Publications
- 20
Are you this provider?
Claim Your Profile